154 related articles for article (PubMed ID: 38087447)
1. The role of sex hormones and receptors in HBV infection and development of HBV-related HCC.
Nuermaimaiti A; Chang L; Yan Y; Sun H; Xiao Y; Song S; Feng K; Lu Z; Ji H; Wang L
J Med Virol; 2023 Dec; 95(12):e29298. PubMed ID: 38087447
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of gender disparity in hepatitis B virus-associated hepatocellular carcinoma.
Liu WC; Liu QY
World J Gastroenterol; 2014 May; 20(20):6252-61. PubMed ID: 24876746
[TBL] [Abstract][Full Text] [Related]
3. Gender disparity in chronic hepatitis B: Mechanisms of sex hormones.
Wang SH; Chen PJ; Yeh SH
J Gastroenterol Hepatol; 2015 Aug; 30(8):1237-45. PubMed ID: 25708186
[TBL] [Abstract][Full Text] [Related]
4. Review article: the prevention of hepatitis B-related hepatocellular carcinoma.
Lin CL; Kao JH
Aliment Pharmacol Ther; 2018 Jul; 48(1):5-14. PubMed ID: 29722445
[TBL] [Abstract][Full Text] [Related]
5. Gender disparity in hepatocellular carcinoma (HCC): multiple underlying mechanisms.
Zheng B; Zhu YJ; Wang HY; Chen L
Sci China Life Sci; 2017 Jun; 60(6):575-584. PubMed ID: 28547581
[TBL] [Abstract][Full Text] [Related]
6. Sex-Dependent Outcome of Hepatitis B and C Viruses Infections: Synergy of Sex Hormones and Immune Responses?
Ruggieri A; Gagliardi MC; Anticoli S
Front Immunol; 2018; 9():2302. PubMed ID: 30349537
[TBL] [Abstract][Full Text] [Related]
7. Androgen Receptor Enhances Hepatic Telomerase Reverse Transcriptase Gene Transcription After Hepatitis B Virus Integration or Point Mutation in Promoter Region.
Li CL; Li CY; Lin YY; Ho MC; Chen DS; Chen PJ; Yeh SH
Hepatology; 2019 Feb; 69(2):498-512. PubMed ID: 30070724
[TBL] [Abstract][Full Text] [Related]
8. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
[TBL] [Abstract][Full Text] [Related]
9. The dual role of regulatory T cells in hepatitis B virus infection and related hepatocellular carcinoma.
He J; Miao R; Chen Y; Wang H; Liu M
Immunology; 2024 Apr; 171(4):445-463. PubMed ID: 38093705
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus-induced hepatocarcinogenesis: A virological and oncological perspective.
Arslan F; Franci G; Maria Nastri B; Pagliano P
J Viral Hepat; 2021 Aug; 28(8):1104-1109. PubMed ID: 34003561
[TBL] [Abstract][Full Text] [Related]
11. Relative etiological role of prior hepatitis B virus infection and nonalcoholic fatty liver disease in the development of non-B non-C hepatocellular carcinoma in a hepatitis B-endemic area.
Cho EJ; Kwack MS; Jang ES; You SJ; Lee JH; Kim YJ; Yoon JH; Lee HS
Digestion; 2011; 84 Suppl 1():17-22. PubMed ID: 22156481
[TBL] [Abstract][Full Text] [Related]
12. [Occult hepatitis B virus infection and hepatocellular carcinoma].
Lee JJ; Kwon OS
Korean J Gastroenterol; 2013 Sep; 62(3):160-4. PubMed ID: 24077626
[TBL] [Abstract][Full Text] [Related]
13. Incidence of development of hepatocellular carcinoma in Japanese patients infected with hepatitis B virus is equivalent between genotype B and C in long term.
Haga H; Saito T; Okumoto K; Tomita K; Katsumi T; Mizuno K; Nishina T; Watanabe H; Ueno Y
J Viral Hepat; 2019 Jul; 26(7):866-872. PubMed ID: 30924226
[TBL] [Abstract][Full Text] [Related]
14. Role of Sex Hormones in the Development and Progression of Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Montella M; D'Arena G; Crispo A; Capunzo M; Nocerino F; Grimaldi M; Barbieri A; D'Ursi AM; Tecce MF; Amore A; Galdiero M; Ciliberto G; Giudice A
Int J Endocrinol; 2015; 2015():854530. PubMed ID: 26491442
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal.
Shrestha SM; Shrestha S; Shrestha A; Tsuda F; Endo K; Takahashi M; Okamoto H
J Gastroenterol Hepatol; 2007 Nov; 22(11):1921-8. PubMed ID: 17914971
[TBL] [Abstract][Full Text] [Related]
16. High Level of Hepatitis B Core-Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load.
Tseng TC; Liu CJ; Hsu CY; Hong CM; Su TH; Yang WT; Chen CL; Yang HC; Huang YT; Fang-Tzu Kuo S; Liu CH; Chen PJ; Chen DS; Kao JH
Gastroenterology; 2019 Dec; 157(6):1518-1529.e3. PubMed ID: 31470004
[TBL] [Abstract][Full Text] [Related]
17. Universal HBV vaccination dramatically reduces the prevalence of HBV infection and incidence of hepatocellular carcinoma.
Wong GL; Hui VW; Yip TC; Liang LY; Zhang X; Tse YK; Lai JC; Chan HL; Wong VW
Aliment Pharmacol Ther; 2022 Sep; 56(5):869-877. PubMed ID: 35864571
[TBL] [Abstract][Full Text] [Related]
18. State of the art treatment of hepatitis B virus hepatocellular carcinoma and the role of hepatitis B surface antigen post-liver transplantation and resection.
Schemmer P; Burra P; Hu RH; Hüber CM; Loinaz C; Machida K; Vogel A; Samuel D
Liver Int; 2022 Feb; 42(2):288-298. PubMed ID: 34846790
[TBL] [Abstract][Full Text] [Related]
19. Changing relative roles of hepatitis B and C viruses in the aetiology of hepatocellular carcinoma in Greece. Epidemiological and clinical observations.
Raptis I; Koskinas J; Emmanouil T; Hadziyannis S
J Viral Hepat; 2003 Nov; 10(6):450-4. PubMed ID: 14633179
[TBL] [Abstract][Full Text] [Related]
20. Risk stratification for hepatitis B virus related hepatocellular carcinoma.
Lin CL; Kao JH
J Gastroenterol Hepatol; 2013 Jan; 28(1):10-7. PubMed ID: 23094699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]